Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment

Descripción del Articulo

Objective: To determine the enzymatic biochemical parameters (glutamic pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST), alkaline phosphatase (ALP), gamma glutamyltransferase (y-GT), and lactate dehydrogenase (LDH)) in children with acute lymphoblastic leukemia (ALL) before cancer...

Descripción completa

Detalles Bibliográficos
Autores: Moya S., Jeél, Pio D., Liz
Formato: artículo
Fecha de Publicación:2015
Institución:Universidad de San Martín de Porres
Repositorio:Horizonte médico
Lenguaje:español
OAI Identifier:oai:horizontemedico.usmp.edu.pe:article/341
Enlace del recurso:https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341
Nivel de acceso:acceso abierto
Materia:ALT
AST
ALP
y-GT
LDH
Dehydrogenase
Acute Lymphatic Leukemia
Leucemia Linfoblastica Aguda
id REVHM_249b2e227c0a3f89bd918782fb396e7b
oai_identifier_str oai:horizontemedico.usmp.edu.pe:article/341
network_acronym_str REVHM
network_name_str Horizonte médico
repository_id_str
dc.title.none.fl_str_mv Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment
Parámetros bioquímicos enzimáticos (ALT, AST, ALP, γ-GT, LDH) en niños con leucemia linfoblástica aguda antes del tratamiento antineoplásico
title Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment
spellingShingle Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment
Moya S., Jeél
ALT
AST
ALP
y-GT
LDH
Dehydrogenase
Acute Lymphatic Leukemia
ALT
AST
ALP
y-GT
LDH
Leucemia Linfoblastica Aguda
title_short Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment
title_full Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment
title_fullStr Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment
title_full_unstemmed Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment
title_sort Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment
dc.creator.none.fl_str_mv Moya S., Jeél
Pio D., Liz
author Moya S., Jeél
author_facet Moya S., Jeél
Pio D., Liz
author_role author
author2 Pio D., Liz
author2_role author
dc.subject.none.fl_str_mv ALT
AST
ALP
y-GT
LDH
Dehydrogenase
Acute Lymphatic Leukemia
ALT
AST
ALP
y-GT
LDH
Leucemia Linfoblastica Aguda
topic ALT
AST
ALP
y-GT
LDH
Dehydrogenase
Acute Lymphatic Leukemia
ALT
AST
ALP
y-GT
LDH
Leucemia Linfoblastica Aguda
description Objective: To determine the enzymatic biochemical parameters (glutamic pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST), alkaline phosphatase (ALP), gamma glutamyltransferase (y-GT), and lactate dehydrogenase (LDH)) in children with acute lymphoblastic leukemia (ALL) before cancer treatment. Material and Methods: A prospective experimental, observational, cross-sectional study was conducted in 30 children between 2 and 15 years old, from several Neoplastic Centers in Lima. Blood collection was performed in BD red cap Vacutainer tubes, processed in the semi-automated analyzer BIOTEC® EMP-168, with Wiener Lab Group enzyme reagents under the modified method Szaaz and UV-Optimized by IFCC, SSCC and SFBC. Finally, coding and tabulation was performed. Results: 60% were boys and 46.7% are between the ages of 2-6 years. Serum levels of AST were increased by 33.3% in boys and 50% in girls. Serum ALT values were increased in 33.3% of boys and 41.7% of girls; only 25% of girls showed increased levels of y-GT values; ALP was increased in 44.4% of boys and 66.7% of girls. Moreover LDH levels were increased in 55.6% of boys and 41.7% of girls. Conclusion: The enzymatic tests LDH, AST, ALT and ALP are increased in children with ALL compared to normal values due to tumor lysis syndrome characterized by electrolyte abnormalities, and as a result of the massive destruction of tumor cells and rapid release of large amounts of intracellular elements.
publishDate 2015
dc.date.none.fl_str_mv 2015-12-14
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341
10.24265/horizmed.2015.v15n4.08
url https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341
identifier_str_mv 10.24265/horizmed.2015.v15n4.08
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341/303
dc.rights.none.fl_str_mv Derechos de autor 2015 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2015 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
dc.source.none.fl_str_mv Horizonte Médico (Lima); Vol. 15 No. 4 (2015): October - December; 52-58
Horizonte Médico (Lima); Vol. 15 Núm. 4 (2015): Octubre - Diciembre; 52-58
Horizonte Médico (Lima); v. 15 n. 4 (2015): Octubre - Diciembre; 52-58
2227-3530
1727-558X
10.24265/horizmed.2015.v15n4
reponame:Horizonte médico
instname:Universidad de San Martín de Porres
instacron:USMP
instname_str Universidad de San Martín de Porres
instacron_str USMP
institution USMP
reponame_str Horizonte médico
collection Horizonte médico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1844720556737298432
spelling Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatmentParámetros bioquímicos enzimáticos (ALT, AST, ALP, γ-GT, LDH) en niños con leucemia linfoblástica aguda antes del tratamiento antineoplásicoMoya S., JeélPio D., LizALTASTALPy-GTLDHDehydrogenaseAcute Lymphatic LeukemiaALTASTALPy-GTLDHLeucemia Linfoblastica AgudaObjective: To determine the enzymatic biochemical parameters (glutamic pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST), alkaline phosphatase (ALP), gamma glutamyltransferase (y-GT), and lactate dehydrogenase (LDH)) in children with acute lymphoblastic leukemia (ALL) before cancer treatment. Material and Methods: A prospective experimental, observational, cross-sectional study was conducted in 30 children between 2 and 15 years old, from several Neoplastic Centers in Lima. Blood collection was performed in BD red cap Vacutainer tubes, processed in the semi-automated analyzer BIOTEC® EMP-168, with Wiener Lab Group enzyme reagents under the modified method Szaaz and UV-Optimized by IFCC, SSCC and SFBC. Finally, coding and tabulation was performed. Results: 60% were boys and 46.7% are between the ages of 2-6 years. Serum levels of AST were increased by 33.3% in boys and 50% in girls. Serum ALT values were increased in 33.3% of boys and 41.7% of girls; only 25% of girls showed increased levels of y-GT values; ALP was increased in 44.4% of boys and 66.7% of girls. Moreover LDH levels were increased in 55.6% of boys and 41.7% of girls. Conclusion: The enzymatic tests LDH, AST, ALT and ALP are increased in children with ALL compared to normal values due to tumor lysis syndrome characterized by electrolyte abnormalities, and as a result of the massive destruction of tumor cells and rapid release of large amounts of intracellular elements.Objetivo: Determinar los parámetros bioquímicos enzimáticos (Transaminasa Glutámico Pirúvica (ALT), Transaminasa Glutámico Oxalacetico (AST), Fosfatasa Alcalina (ALP), Gamma Glutamiltransferasa (y-GT), y Lactato Deshidrogenasa (LDH)) en niños con Leucemia Linfoblástica Aguda (LLA) antes del tratamiento antineoplásico. Material y Métodos: Estudio prospectivo experimental, observacional, de corte transversal, en 30 niños con LLA entre 2 y 15 años, en diversos Centros Neoplásicos de Lima. La colecta sanguínea se realizó en tubos BD Vacutainer® de tapa color rojo, procesados en el analizador semiautomatizado BIOTEC® EMP-168, con reactivos enzimáticos de Wiener Lab Group bajo el método modificado de Szaaz y UV-Optimizado por IFCC, SSCC y SFBC. Por último, se realizó la codificación y tabulación de datos. Resultados: El 60% correspondió a niños y el 46,7% corresponde a las edades entre 2 a 6 años. Los niveles séricos de AST estuvieron incrementados en el 33,3% en niños y el 50% en niñas. Los valores séricos de ALT estuvieron incrementados en el 33,3% de niños y en el 41,7% de niñas; solamente el 25% de niñas presentaron valores incrementados de y-GT; la ALP estuvo acrecentada en el 44,4% de niños y en el 66,7% de niñas. Por otro lado los niveles de LDH estuvieron acrecentados en el 55,6% de niños y en el 41,7% de niñas. Conclusión: Las pruebas enzimáticas LDH, AST, ALT y ALP se encuentran aumentados en niños con LLA con respecto a los valores normales, debido al síndrome de lisis tumoral caracterizada por alteraciones electrolíticas, y como consecuencia de la destrucción masiva de células tumorales y la liberación rápida de grandes cantidades de elementos intracelulares.Universidad de San Martín de Porres. Facultad de Medicina Humana2015-12-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/34110.24265/horizmed.2015.v15n4.08Horizonte Médico (Lima); Vol. 15 No. 4 (2015): October - December; 52-58Horizonte Médico (Lima); Vol. 15 Núm. 4 (2015): Octubre - Diciembre; 52-58Horizonte Médico (Lima); v. 15 n. 4 (2015): Octubre - Diciembre; 52-582227-35301727-558X10.24265/horizmed.2015.v15n4reponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspahttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341/303Derechos de autor 2015 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/3412022-08-03T18:18:11Z
score 13.08006
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).